An evaluation led by UNC’s Seth A. Berkowitz, MD, MPH, was published in the Journal of the American Medical Association.

Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine, professor of pediatrics, Division of Pediatric Allergy/Immunology, Department of Pediatrics and Corinne A. Keet, MD, PhD, professor of pediatrics, Division of Pediatric Allergy/Immunology, Department of Pediatrics, write editorial in New England Journal of Medicine Evidence titled, “To Eat or Not to Eat: Oral Immunotherapy for High Threshold Peanut Allergy.”

Co-led by UNC School of Medicine’s David Y. Hwang, MD, newly released updated guidelines from the Society of Critical Care Medicine (SCCM) reveal how family centered care for adult ICUs is paramount and an invaluable approach.

Randomized, placebo-controlled trial finds that low-dose semaglutide reduces amount of alcohol consumption, alcohol cravings, and heavy drinking days. Reductions in cigarettes per day were also seen.

Drug work one of “7 Medical Breakthroughs that Changed Medicine in 2024.”

Researchers in the lab of Janelle Arthur, PhD, associate professor at the Department of Microbiology & Immunology at the UNC School of Medicine, have found a key process by which gut bacteria may be contributing to intestinal fibrosis, a major complication of an intestinal inflammatory disease called Crohn’s disease.

UNC School of Medicine’s Living Donor Liver Transplant program has been recognized by the Organ Procurement and Transplantation Network (OPTN) as a center with expertise to offer Living Donor Liver Transplants. Sorabh Kapoor, MD, Assistant Professor of Surgery, Division of Abdominal Transplantation, will serve as the Surgical Director of the program.

Harvard Neuroscientist David D. Ginty, PhD, will receive the Perl-UNC Neuroscience Prize for his pivotal discoveries on the sensation of touch and how our body communicates with the brain.

Using technology first designed by Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology, researchers at the UNC School of Medicine have engineered a molecular technology that can turn off pain receptors.

The Patient-Centered Outcomes Research Institute (PCORI) announced funding totaling $14.4 million for a Duke-UNC research collaboration to study new treatment options for pediatric inflammatory bowel diseases (PIBD). Michael D. Kappelman, MD, MPH, professor of pediatrics and epidemiology at the UNC School of Medicine, will serve as principal investigator.

The UNC Special Pathogens Response Center (SPARC) at UNC Hospitals is a regional and national resource for safely caring for patients with a special pathogen. Get an inside look on how healthcare professionals prepare and train during an exercise at the UNC Medical Center.

A comprehensive analysis published in the journal Gastroenterology and led by Michael D. Kappelman, MD, MPH, at the UNC School of Medicine, reveals that U.S. pediatric IBD rates have increased, ranking among the highest globally.

Tag: UNC School of Medicine

NC Healthy Opportunities Program Helped Reduce Medicaid Costs

Burks and Keet Publish Editorial on Oral Immunotherapy for High Threshold Peanut Allergy

A Fresh Approach to Family-Centered Care for Adult ICUs

Semaglutide Shows Promise in Reducing Cravings for Alcohol, Heavy Drinking

UNC ‘Breakthrough’ Research on Food Allergy Drug Featured in National Geographic

Researchers Identify Key Driver of Fibrosis in Crohn’s Disease

UNC School of Medicine’s Living Donor Liver Transplant Program Receives Full Approval

Ginty Named 23rd Perl-UNC Neuroscience Prize Recipient

Researchers Create Gene Therapy with Potential to Treat Peripheral Pain Conditions

PCORI Awards UNC Researcher $14.4 Million to Study Emerging Medications for PIBD Patients

READY TO RESPOND: An Inside Look Into UNC’s SPARC Program

Kappelman Leads Landmark Study Revealing That 100,000 American Youth Are Living with Inflammatory Bowel Disease